Neonatal Predictors of Infection Status and Early Death Among 332 Infants at Risk of HIV-1 Infection Monitored Prospectively From Birth

¹ Harlem Hospital, New York, NY
² Medical and Health Research Association, Inc., New York, NY
³ New York City Department of Health, New York, NY
⁴ NYU-Bellevue Medical Center, New York, NY
⁵ Bronx-Lebanon Hospital, New York, NY
⁶ Centers for Disease Control and Prevention, Atlanta, GA
⁷ Metropolitan Hospital, New York, NY
⁸ Center for Comprehensive Health Practice, New York, NY
⁹ Mt. Sinai Hospital, New York, NY
¹⁰ Lincoln Hospital Center; New York, NY

Background and Methods. Differences in newborn outcome measures for human immunodeficiency virus (HIV)-1-infected and HIV-1-exposed but uninfected infants have been found in several studies, but not in others. Eighty-four infected and 248 uninfected children born to HIV-1-seropositive mothers followed prospectively in a multicenter, perinatal HIV-1 transmission cohort study were compared for differences in maternal demographics, health status, and newborn outcome measures, including delivery complications, physical examination findings, neonatal complications, and laboratory results.

Results. Mothers of HIV-1-infected infants were more likely than those of uninfected infants to have acquired immunodeficiency syndrome (AIDS) diagnosed through 2 weeks postpartum (21% vs 11%, P = .04); the transmission rate for the 38 women with AIDS was 37% compared with 22% for the 245 women without AIDS. Two of 27 (7%) women receiving zidovudine during pregnancy had infected infants compared with 73 (27%) of 275 women who did not receive zidovudine (P = .033). Mean gestational age was significantly lower among HIV-1-infected (37 weeks) than among uninfected infants (38 weeks; P < .001). Infected infants had significantly higher rates of prematurity (gestational age less than 37 weeks) (33% vs 19%, P = .01) and extreme prematurity (gestational age less than 34 weeks) (18% vs 6%, P = .001) than uninfected infants. Infection was associated with lower birth weight (2533 g vs 2862 g, P < .001) and smaller head circumference (32.0 cm vs 33.1 cm, P = .001). HIV-1-infected infants were significantly more likely to be small for gestational age (26% vs 16%, P = .04) and low birth weight (less than 2500 g) (45% vs 29%, P = .006) than infants who were uninfected. Twenty-two (26%) HIV-1-infected children died during a median follow-up of 27.6 months (range 1.9 to 98.3 months). Prematurity was predictive of survival: by Kaplan-Meier, an estimated 55% (95% confidence interval, 31% to 72%) of preterm infected children survived to 24 months compared with 84% (95% confidence interval, 70% to 92%) of full-term infected children (P = .005).

Conclusion. Infants born to women with AIDS are at higher risk for HIV-1 infection than are infants born to HIV-1-infected women with AIDS not yet diagnosed. Women receiving zidovudine appear less likely to transmit HIV-1 to their infants. Significantly higher rates of prematurity and intrauterine growth retardation were found among HIV-1-infected infants than among those in the uninfected, HIV-1-exposed control group. Prematurity was associated with shortened survival in HIV-1-infected infants. Measures of intrauterine growth and gestation appear to be important predictors of HIV-1 infection status for seropositive infants and of prognosis for the infected infant.

This article has been cited by other articles:

				R. Kupka, F. Mugusi, S. Aboud, G. I Msamanga, J. L Finkelstein, D. Spiegelman, and W. W Fawzi Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1802 - 1808. [Abstract] [Full Text] [PDF]

				C. T. T. Edwards, E. C. Holmes, O. G. Pybus, D. J. Wilson, R. P. Viscidi, E. J. Abrams, R. E. Phillips, and A. J. Drummond Evolution of the Human Immunodeficiency Virus Envelope Gene Is Dominated by Purifying Selection Genetics, November 1, 2006; 174(3): 1441 - 1453. [Abstract] [Full Text] [PDF]

				K. T. Chen, M. Segu, L. H. Lumey, L. Kuhn, R. J. Carter, M. Bulterys, E. J. Abrams, and for the New York City Perinatal AIDS Collaborative Genital Herpes Simplex Virus Infection and Perinatal Transmission of Human Immunodeficiency Virus Obstet. Gynecol., December 1, 2005; 106(6): 1341 - 1348. [Abstract] [Full Text] [PDF]

				F. Jahoor, S. Abramson, and W. C Heird The protein metabolic response to HIV infection in young children Am. J. Clinical Nutrition, July 1, 2003; 78(1): 182 - 189. [Abstract] [Full Text] [PDF]

				S. Chearskul, T. Chotpitayasunondh, R. J. Simonds, N. Wanprapar, N. Waranawat, W. Punpanich, K. Chokephaibulkit, P. A. Mock, K. Neeyapun, B. Jetsawang, et al. Survival, Disease Manifestations, and Early Predictors of Disease Progression Among Children With Perinatal Human Immunodeficiency Virus Infection in Thailand Pediatrics, August 1, 2002; 110(2): e25 - 25. [Abstract] [Full Text] [PDF]

				M. L Dreyfuss, G. I Msamanga, D. Spiegelman, D. J Hunter, E. J. Urassa, E. Hertzmark, and W. W Fawzi Determinants of low birth weight among HIV-infected pregnant women in Tanzania Am. J. Clinical Nutrition, December 1, 2001; 74(6): 814 - 826. [Abstract] [Full Text]

				D. Candal, M. Bulterys, E. J. Abrams, R. W. Steketee, and B. S. Parekh Efficacy of a Less-Sensitive Enzyme Immunoassay (3A11-LS) for Early Diagnosis of Human Immunodeficiency Virus Type 1 Infection in Infants Clin. Vaccine Immunol., November 1, 2001; 8(6): 1282 - 1285. [Abstract] [Full Text] [PDF]

				L. M. Mofenson, J. S. Lambert, E. R. Stiehm, J. Bethel, W. A. Meyer, J. Whitehouse, J. Moye, P. Reichelderfer, D. R. Harris, M. G. Fowler, et al. Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine N. Engl. J. Med., August 5, 1999; 341(6): 385 - 393. [Abstract] [Full Text] [PDF]

				T. J. Starc, C. Langston, J. Goldfarb, A. A. Colin, E. R. Cooper, K. A. Easley, S. Sunkle, M. D. Schluchter, for the Pediatric Pulmonary and Cardiac Complicati, L. a. B. Institute, et al. Unexpected Non-HIV Causes of Death in Children Born to HIV-Infected Mothers Pediatrics, July 1, 1999; 104(1): 6e - 6. [Abstract] [Full Text]

				T. Italian Collaborative Study on HIV infection in pr Mother-to-child transmission of human immunodeficiency virus in Italy: temporal trends and determinants of infection Hum. Reprod., January 1, 1999; 14(1): 242 - 246. [Abstract] [Full Text] [PDF]

				S. Weng, M. Bulterys, A. Chao, C. A. Stidley, A. Dushimimana, E. Mbarutso, and A. Saah Perinatal Human Immunodeficiency Virus-1 Transmission and Intrauterine Growth: A Cohort Study in Butare, Rwanda Pediatrics, August 1, 1998; 102(2): e24 - 24. [Abstract] [Full Text] [PDF]

				M. Mirochnick, E. Capparelli, W. Dankner, R. S. Sperling, R. van Dyke, and S. A. Spector Zidovudine Pharmacokinetics in Premature Infants Exposed to Human Immunodeficiency Virus Antimicrob. Agents Chemother., April 1, 1998; 42(4): 808 - 812. [Abstract] [Full Text]

				S. H. Landesman, L. A. Kalish, D. N. Burns, H. Minkoff, H. E. Fox, C. Zorrilla, P. Garcia, M. G. Fowler, L. Mofenson, R. Tuomala, et al. Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child N. Engl. J. Med., June 20, 1996; 334(25): 1617 - 1623. [Abstract] [Full Text] [PDF]

	Home | My Pediatrics | Journal Information | Current Issue | Past Issues | Subscriptions & Services | Contact Us Click here for faster international access © 1995 American Academy of Pediatrics. All rights reserved.